Rare diseases
Investigational molecules
Locations
Study of Elacestrant and Ribociclib for Patients with Endocrine-Responsive HER2-Negative Early Breast Cancer
AustriaStudy of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation
FranceStudy Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
AustriaLong-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial
GermanyStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis
FranceStudy for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib
ItalyStudy on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors
FranceStudy on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension
BelgiumStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
BelgiumTitle: Long-term safety and effectiveness study of ulviprubart in patients with inclusion body myositis who completed previous treatment
BelgiumStudy of CLU-RX-BET injection therapy for patients with moderate to severe birch pollen allergies
GermanyComparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
